These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 17374626

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Eosinophilic pneumonia caused by daptomycin: Six cases from two institutions and a review of the literature.
    Hirai J, Hagihara M, Haranaga S, Kinjo T, Hashioka H, Kato H, Sakanashi D, Yamagishi Y, Mikamo H, Fujita J.
    J Infect Chemother; 2017 Apr; 23(4):245-249. PubMed ID: 28003110
    [Abstract] [Full Text] [Related]

  • 23. [Bilateral hilar and mediastinal lymphadenopathy accomporying pulmonary infiltration with eosinophilia].
    Nakamura H, Kashiwabara K, Narushima K, Adachi H, Tsuchida F, Kishi K, Yagyu H, Kiguchi T, Matsuoka K, Kusama H.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Apr; 35(4):447-50. PubMed ID: 9212672
    [Abstract] [Full Text] [Related]

  • 24. A rare cause of pulmonary infiltrates one should be aware of: a case of daptomycin-induced acute eosinophilic pneumonia.
    Rether C, Conen A, Grossenbacher M, Albrich WC.
    Infection; 2011 Dec; 39(6):583-5. PubMed ID: 21717147
    [Abstract] [Full Text] [Related]

  • 25. Clinical characteristics, management, and outcome of eosinophilic pneumonia associated with daptomycin.
    Wu C, Li Z, Wang C, Deng Z.
    Med Clin (Barc); 2023 Jan 05; 160(1):17-22. PubMed ID: 35840367
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Eosinophilic pneumonia in patients treated with daptomycin: review of the literature and US FDA adverse event reporting system reports.
    Kim PW, Sorbello AF, Wassel RT, Pham TM, Tonning JM, Nambiar S.
    Drug Saf; 2012 Jun 01; 35(6):447-57. PubMed ID: 22612850
    [Abstract] [Full Text] [Related]

  • 28. Daptomycin-induced eosinophilia without pulmonary involvement.
    Doan TL, DePetrillo J, Singer C.
    Am J Health Syst Pharm; 2010 Dec 15; 67(24):2107-9. PubMed ID: 21116001
    [Abstract] [Full Text] [Related]

  • 29. Daptomycin-induced eosinophilic pneumonia.
    Hassett MR.
    JAAPA; 2024 Apr 01; 37(4):1-4. PubMed ID: 38531037
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Diltiazem-induced eosinophilic pleural effusion.
    Raptis L, Pappas G, Katsanou A, Koutsouka F, Petrakis D, Akritidis N.
    Pharmacotherapy; 2007 Apr 01; 27(4):600-2. PubMed ID: 17381387
    [Abstract] [Full Text] [Related]

  • 34. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
    Ardura MI, Mejías A, Katz KS, Revell P, McCracken GH, Sánchez PJ.
    Pediatr Infect Dis J; 2007 Dec 01; 26(12):1128-32. PubMed ID: 18043450
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.
    Moise PA, Hershberger E, Amodio-Groton MI, Lamp KC.
    Ann Pharmacother; 2009 Jul 01; 43(7):1211-9. PubMed ID: 19584384
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.